triple

Documents about triple

• Maximum packing for perfect four-triple configurations#955115Koc University Digital Collections
• Reverse Triple Negative Immune Resistant Breast Cancer#325309ClinicalTrials.gov
• SAQMMA11F0677 — TRIPLE CANOPY INC — Department of State ($948,929,794)#605223USAspending
• Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)#844744ClinicalTrials.gov
• A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer#859622ClinicalTrials.gov
• Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer#387169ClinicalTrials.gov
• MicroRNA Profiles in Triple Negative Breast Cancer#141066ClinicalTrials.gov
• Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer#245507ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy#234493ClinicalTrials.gov
• Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer#917821ClinicalTrials.gov
• Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy#123570ClinicalTrials.gov
• Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)#909685ClinicalTrials.gov
• Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer#853755ClinicalTrials.gov
• Efficacy of Interleukin-2 in Triple Negative Breast Cancer#307467ClinicalTrials.gov
• Neoadjuvant Goserelin for Triple Negative Breast Cancer#860939ClinicalTrials.gov
• Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer#28435ClinicalTrials.gov
• QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine#387197ClinicalTrials.gov
• Three Types of Negation of Triple and its Elements and an Extension of Triple#985642arXiv (All)
• Triple-Negative Breast Cancer Versus Non-Triple-Negative Breast Cancer: The Impact of Pd and Pt Complexes on Basal-Like Triple-Negative Breast Cancer.#170565NCBI PubMed Central
• Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer#801676ClinicalTrials.gov
• Triple Deck Vending - Topgacha.com#417842Figshare
• The Effect of Lateral Deviation on Triple Jump Performance#958477Louisiana Tech Digital Commons
• Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer#852144ClinicalTrials.gov
• Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.#900025ClinicalTrials.gov
• Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients#287389ClinicalTrials.gov
• Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer#366591ClinicalTrials.gov
• Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery#383568ClinicalTrials.gov
• TNBC Gut Microbiota During Neoadjuvant Treatment#405156ClinicalTrials.gov
• Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy#234433ClinicalTrials.gov
• The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer#800289ClinicalTrials.gov
• Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer#810240ClinicalTrials.gov
• "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer#174862ClinicalTrials.gov
• Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer#272340ClinicalTrials.gov
• Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer#321549ClinicalTrials.gov
• Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1#845678ClinicalTrials.gov
• Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer#848282ClinicalTrials.gov
• A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies#849810ClinicalTrials.gov
• Triple definition of complexity#72055PhilArchive
• 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)#18622ClinicalTrials.gov
• VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study#67874ClinicalTrials.gov
• Study on Bisphosphonates Targeting Triple-negative Breast Cancer#851034ClinicalTrials.gov
• 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication#874327ClinicalTrials.gov
• Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer#890974ClinicalTrials.gov
• Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy#181759ClinicalTrials.gov
• Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer#300271ClinicalTrials.gov
• PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer#405149ClinicalTrials.gov
• Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer#864678ClinicalTrials.gov
• ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer#878385ClinicalTrials.gov
• QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer#884216ClinicalTrials.gov
• Ejercicios pliométricos para mejorar la fuerza explosiva en atletas en el salto triple.#936149Repositorio Universidad Estatal Peninsula de Santa Elena